Effect of sodium bicarbonate on functional outcome in patients with out-of-hospital cardiac arrest: a post-hoc analysis of a French and North-American dataset

Eur J Emerg Med. 2022 Jun 1;29(3):210-220. doi: 10.1097/MEJ.0000000000000918. Epub 2022 Mar 16.

Abstract

Background and importance: No large randomised controlled trial has assessed the potential benefits on neurologic outcomes of prehospital sodium bicarbonate administration in patients with nontraumatic out-of-hospital cardiac arrest (OHCA).

Objective: To obtain information of assistance in designing a randomised controlled trial of bicarbonate therapy after OHCA in specific patient subgroups.

Design: We conducted two, separate, simultaneous, retrospective studies of two distinct, unlinked datasets.

Setting and participants: One dataset was a French nationwide population-based registry (RéAC Registry, French dataset) and the other was a randomised controlled trial comparing continuous to interrupted chest compressions in North America (ROC-CCC trial, North-American dataset).

Intervention: We investigated whether prehospital bicarbonate administration was associated with better neurologic outcomes.

Outcome measures and analyses: The main outcome measure was the functional outcome at hospital discharge. To adjust for potential confounders, we conducted a nested propensity-score-matched analysis with inverse probability-of-treatment weighting.

Main results: In the French dataset, of the 54 807 patients, 1234 (2.2%) received sodium bicarbonate and 450 were matched. After propensity-score matching, sodium bicarbonate was not associated with a higher likelihood of favourable functional outcomes on day 30 [adjusted odds ratio (aOR), 0.912; 95% confidence interval (95%CI), 0.501-1.655]. In the North-American dataset, of the 23 711 included patients, 4902 (20.6%) received sodium bicarbonate and 1238 were matched. After propensity-score matching, sodium bicarbonate was associated with a lower likelihood of favourable functional outcomes at hospital discharge (aOR, 0.45; 95% CI, 0.34-0.58).

Conclusion: In patients with OHCA, prehospital sodium bicarbonate administration was not associated with neurologic outcomes in a French dataset and was associated with worse neurologic outcomes in a North-American dataset. Given the considerable variability in sodium bicarbonate use by different prehospital care systems and the potential resuscitation-time bias in the present study, a large randomised clinical trial targeting specific patient subgroups may be needed to determine whether sodium bicarbonate has a role in the prehospital management of prolonged OHCA.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Bicarbonates / therapeutic use
  • Cardiopulmonary Resuscitation*
  • Emergency Medical Services*
  • Humans
  • Out-of-Hospital Cardiac Arrest* / drug therapy
  • Registries
  • Retrospective Studies
  • Sodium Bicarbonate / therapeutic use

Substances

  • Bicarbonates
  • Sodium Bicarbonate